These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10948110)

  • 1. Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.
    de Haas CJ; Poppelier MJ; van Kessel KP; van Strijp JA
    Infect Immun; 2000 Sep; 68(9):4954-60. PubMed ID: 10948110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS.
    de Haas CJ; van Leeuwen HJ; Verhoef J; van Kessel KP; van Strijp JA
    J Immunol Methods; 2000 Aug; 242(1-2):79-89. PubMed ID: 10986391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
    J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.
    Wurfel MM; Kunitake ST; Lichenstein H; Kane JP; Wright SD
    J Exp Med; 1994 Sep; 180(3):1025-35. PubMed ID: 8064223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS.
    de Haas CJ; van der Zee R; Benaissa-Trouw B; van Kessel KP; Verhoef J; van Strijp JA
    Infect Immun; 1999 Jun; 67(6):2790-6. PubMed ID: 10338482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
    Wurfel MM; Wright SD
    Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.
    Levels JH; Marquart JA; Abraham PR; van den Ende AE; Molhuizen HO; van Deventer SJ; Meijers JC
    Infect Immun; 2005 Apr; 73(4):2321-6. PubMed ID: 15784577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.
    Wurfel MM; Hailman E; Wright SD
    J Exp Med; 1995 May; 181(5):1743-54. PubMed ID: 7536794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein.
    Vosbeck K; Tobias P; Mueller H; Allen RA; Arfors KE; Ulevitch RJ; Sklar LA
    J Leukoc Biol; 1990 Feb; 47(2):97-104. PubMed ID: 2154525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I.
    Massamiri T; Tobias PS; Curtiss LK
    J Lipid Res; 1997 Mar; 38(3):516-25. PubMed ID: 9101432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein.
    Li XA; Yutani C; Shimokado K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):249-52. PubMed ID: 9514915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.
    Hamann L; Alexander C; Stamme C; Zähringer U; Schumann RR
    Infect Immun; 2005 Jan; 73(1):193-200. PubMed ID: 15618154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes.
    Vesy CJ; Kitchens RL; Wolfbauer G; Albers JJ; Munford RS
    Infect Immun; 2000 May; 68(5):2410-7. PubMed ID: 10768924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein.
    Hailman E; Albers JJ; Wolfbauer G; Tu AY; Wright SD
    J Biol Chem; 1996 May; 271(21):12172-8. PubMed ID: 8647810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein.
    Thompson PA; Kitchens RL
    J Immunol; 2006 Oct; 177(7):4880-7. PubMed ID: 16982930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.
    de Haas CJ; van Leeuwen EM; van Bommel T; Verhoef J; van Kessel KP; van Strijp JA
    Infect Immun; 2000 Apr; 68(4):1753-9. PubMed ID: 10722560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.
    Troelstra A; Antal-Szalmas P; de Graaf-Miltenburg LA; Weersink AJ; Verhoef J; Van Kessel KP; Van Strijp JA
    Infect Immun; 1997 Jun; 65(6):2272-7. PubMed ID: 9169763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
    Yu B; Hailman E; Wright SD
    J Clin Invest; 1997 Jan; 99(2):315-24. PubMed ID: 9006000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.
    Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP
    J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
    J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.